Research on vaccines during pregnancy: Protocol design and assessment of safety

Vaccine

Volumn 31, Issue 40, 2013, Pages 4274-4279

  Munoz, Flor M ^a   Sheffield, Jeanne S ^b   Beigi, Richard H ^c   Read, Jennifer S ^d   Swamy, Geeta K ^e   Jevaji, Indira ^f,m   Rasmussen, Sonja A ^g   Edwards, Kathryn M ^h   Fortner, Kimberly B ⁱ   Patel, Shital M ^a   Spong, Catherine Y ^j   Ault, Kevin ^k   Heine, R Philips ^e   Nesin, Mirjana ^l  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^m Division of ESRD Population and Community Health (DEPCH)   (United States)

more..

Author keywords

Adverse events; Clinical trials; Definitions; Maternal immunization; Pregnancy studies; Safety

Indexed keywords

VACCINE;

ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; DRUG SAFETY; HUMAN; IMMUNIZATION; PRACTICE GUIDELINE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL;

ADVERSE EVENTS; CLINICAL TRIALS; DEFINITIONS; MATERNAL IMMUNIZATION; PREGNANCY STUDIES; SAFETY;

CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RESEARCH DESIGN; VACCINATION; VACCINES;

EID: 84882953409     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.042     Document Type: Article

References (51)

1. WHO Maternal and Neonatal Tetanus Elimination (MNTE) Initiative 2013, Available from: http://www.who.int/immunization_monitoring/diseases/MNTE_initiative/en/index.html [accessed 03.08.13].
2. Centers for Disease Control and Prevention.Prevention and Control of Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report 2010, 59:1-62.
3. Zaman K. Effectiveness of maternal influenza immunization in mothers and infants. New England Journal of Medicine 2008, 359:1155-1164.
4. American College of Obstetricians and Gynecologists Influenza vaccination during pregnancy. ACOG Committee Opinion Number 468. Obstetrics and Gynecology 2010, 116:1006-1007.
5. Centers for Disease Control and Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP). MMWR: Morbidity and Mortality Weekly Report 2011, (October). Available from: http://ww.cdc.gov/mmwr/preview/mmwrhtml/mm6041a4.htm [accessed 03.07.13].
6. American College of Obstetricians and Gynecologists Update on immunization and pregnancy: tetanus, diphtheria and pertussis vaccination. ACOG Committee Opinion Number 438. Obstetrics and Gynecology 2009, 114:398-400.
7. Centers for Disease Control and Prevention Guidelines for Vaccinating Pregnant Women 2012, CDC, Available from: http://www.cdc.gov/vaccines/pubs/preg-guide.htm.
8. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices (ACIP) Guidelines for Vaccinating Pregnant Women July 2012, CDC, Available from: http://www.cdc.gov/vaccines/pubs/downloads/b_preg_guide.pdf.
9. American College of Obstetricians and Gynecologists Immunization during pregnancy. ACOG Committee Opinion Number 282. Obstetrics and Gynecology 2003, 101:207-212.
10. Marshall V., Gruber M. Influenza immunization during pregnancy: US regulatory perspective. American Journal of Obstetrics and Gynecology 2012, 207(Suppl.):S57-S62.
11. US FDA Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Federal Register 2008, 73:30831-30868.
12. Munoz F.M., Englund J.A. A step ahead, infant protection through maternal immunization. Pediatric Clinics of North America 2000, 47:449-463.
13. Makris M.C., Polyzos K.A., Mavros M.N., Athanasiou S., Rafailidis P.I., Falagas M.E. Safety of hepatitis B, pneumococcal polysaccharide and meningococcal polysaccharide vaccines in pregnancy: a systematic review. Drug Safety 2012, 35:1-14.
14. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health DMID Interventional Protocol Template, version 5.0 March 2011, Available from: http://www.niaid.nih.gov/LabsAndResources/resources/DMIDClinRsrch/Documents/interventional.docx [accessed 03.07.13].
15. Code of Federal Regulations (21CFR, Part 312, Subpart B, 312.32. IND Safety Reporting. Revised April 2012, Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=312.32 [accessed 03.07.13].
16. US FDA Guidance for Industry: Toxicity Grading Scale for Healthy Adult and Adolescent Volunteers Enrolled in Preventive Vaccine Clinical Trials. Revised September 2007, Available from: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/%20Guidances/Vaccines/ucm074775.htm [accessed 03.07.13].
17. Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health DMID Toxicity Tables November 2007, Available from: http://www.niaid.nih.gov/LabsAndResources/resources/DMIDClinRsrch/Documents/dmidadulttox.pdf [accessed 03.07.13].
18. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events (version 1.0), clarification August 2009, Available from: http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table_for_Grading_Severity_of_Adult_Pediatric_Adverse_Events.pdf [accessed 03.07.13].
19. Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events: Addendum 1: Female Genital Grading Table for Use in Microbicide Studies (version 2. 0 3/21/12) 2013, Available from: http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Addendum_1_Female_Genital_Grading_Table_v1_Nov_2007.pdf [accessed 03.07.13].
20. Williams obstetrics 2010, McGraw-Hill, New York. 23rd ed. F. Cunningham, Gary (Eds.).
21. Medline Plus 2013, Available from: http://www.nlm.nih.gov/medlineplus/ [accessed 03.07.13].
22. Up-to-Date 2013, Available from: http://www.uptodate.com/index.
23. Code of Federal Regulations, Title 21 (Food & Drugs), Chapter 1 (FDA & DHHS) 2013, http://www.gpo.gov/fdsys/browse/collectionCfr.action?collectionCode=CFR&searchPath=Title+21%2FChapter+I&oldPath=Title+21%2FChapter+I&isCollapsed=false&selectedYearFrom=2011&ycord=905 [accessed 03.07.13].
24. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Guidelines for Good Clinical Practice E6 (R1) 2013, Available at: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html [accessed 03.07.13].
25. American College of Obstetricians and Gynecologists Ultrasonography in pregnancy. ACOG Practice Bulletin Number 101. Obstetrics and Gynecology 2009, 113:451-461.
26. American College of Obstetricians and Gynecologists Obesity in pregnancy. ACOG Committee Opinion Number 315. Obstetrics and Gynecology 2005, 106:671-675.
27. American College of Obstetricians and Gynecologists Challenges for overweight and obese urban women. ACOG Committee Opinion Number 470. Obstetrics and Gynecology 2010, 116:1011-1014.
28. Vaccine Adverse Event Reporting System (VAERS) 2013, Available from: http://vaers.hhs.gov/esub/index [accessed 03.07.13].
29. Wilcox A.J., Weinberg C.R., O'Connor J.F., Baird D.D., Schlatterer J.P., Canfield R.E., et al. Incidence of early loss of pregnancy. New England Journal of Medicine 1988, 319:189-194.
30. Harlap S., Shiono P.H. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester. Lancet 1980, 2:173-176.
31. American College of Obstetricians and Gynecologists Management of stillbirth. ACOG Practice Bulletin Number 102. Obstetrics and Gynecology 2009, 113:748-761.
32. Chie L., Levine D. Sonography of the lower uterine segment. Ultrasound Clinics 2006, 1:303-319.
33. American College of Obstetricians and Gynecologists Postpartum hemorrhage. ACOG Practice Bulletin, Number 76. Obstetrics and Gynecology 2006, 108:1039-1048.
34. American College of Obstetricians and Gynecologists Premature rupture of membranes. ACOG Practice Bulletin Number 80. Obstetrics and Gynecology 2007, 109:1007-1020.
35. American College of Obstetricians and Gynecologists Cervical insufficiency. ACOG Practice Bulletin Number 48. International Journal of Gynaecology and Obstetrics 2004, 85:81-89.
36. Simhan H.N., Caritis S.N. Prevention of preterm delivery. New England Journal of Medicine 2007, 357:477-487.
37. Hamilton B.E., Martin J.A., Ventura S.J. Births: preliminary data for 2011. National Vital Statistics Reports; vol 61 no 5 2012, National Center for Health Statistics, Hyattsville, MD.
38. American College of Obstetricians and Gynecologists Management of preterm labor. ACOG Practice Bulletin Number 43. International Journal of Gynaecology and Obstetrics 2003, 82:127-135.
39. American College of Obstetricians and Gynecologists Late-preterm infants. ACOG Committee Opinion Number 404. Obstetrics and Gynecology 2008, 111:1029-1032.
40. American College of Obstetricians and Gynecologists Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin Number 33. Obstetrics and Gynecology 2002, 99:159-167.
41. American College of Obstetricians and Gynecologists Chronic hypertension in pregnancy. ACOG Practice Bulletin Number 29. Obstetrics and Gynecology 2001, 98:177-185.
42. American College of Obstetricians and Gynecologists Gestational diabetes. ACOG Practice Bulletin Number 30. Obstetrics and Gynecology 2001, 98:525-538.
43. Rasmussen S.A., Olney R.S., Holmes L.B., Lin A.E., Keppler-Noreuil K.M., Moore C.A. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Research Part A: Clinical and Molecular Teratology 2003, 67:193-201.
44. Marden P.M., Smith D.W., McDonald M.J. Congenital anomalies in the newborn infant, including minor variations. A study of 4,412 babies by surface examination for anomalies and buccal smear for sex chromatin. Journal of Pediatrics 1964, 64:357-371.
45. Méhes K. Paternal trisomy 21 mosaicism and Down's anomaly. Humangenetik 1973, 17:297-300.
46. Leppig K.A., Werler M.M., Cann C.I., Cook C.A., Holmes L.B. Predictive value of minor anomalies. Association with major malformations. Journal of Pediatrics 1987, 110:530-537.
47. Centers for Disease Control and Prevention Update on overall prevalence of major birth defects-Atlanta, Georgia, 1978-2005 2013, MMWR, Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a2.htm [accessed 03.07.13].
48. Nelson K., Holmes L.B. Malformations due to presumed spontaneous mutations in newborn infants. New England Journal of Medicine 1989, 320:19-23.
49. Sadler T.W. Langman's medical embryology 2009, Lippincott Williams and Wilkins, Philadelphia, PA. 11th ed.
50. Stoll B.J., Adams-Chapman I. The high risk infant. Nelson textbook of pediatrics 2007, 703. Elsevier, Philadelphia. 18th ed. R.M. Kliegman (Ed.).
51. Holmes L.B., Westgate M. Inclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogens. Birth Defects Research 2011, 91:807-812.